SCHEMBL20122556

SCHEMBL20122556

CCOC(=O)[C@H](CSC(=O)OCOC(=O)c1ccccc1)NC(=O)C(C)(C)SC(=O)OCOC(=O)c1ccccc1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ADRB2 P07550 2/20 0.39
▸ ADRB1 P08588 2/20 0.39
▸ ADRB3 P13945 2/20 0.39
▸ NPC1 O15118 2/20 0.38
▸ MEN1 O00255 1/20 0.38
▸ KMT2A Q03164 1/20 0.38
▸ SMN1; SMN2 Q16637 4/20 0.37
▸ GAA P10253 1/20 0.37
▸ RAB9A P51151 1/20 0.37
▸ ALDH1A1 P00352 5/20 0.37
▸ HTR1A P08908 1/20 0.37
▸ CYP2D6 P10635 1/20 0.37
▸ SCN1A P35498 1/20 0.37
▸ SLC6A3 Q01959 1/20 0.37
▸ SCN5A Q14524 1/20 0.37
▸ SCN2A Q99250 1/20 0.37
▸ TDP1 Q9NUW8 1/20 0.37
▸ SCN3A Q9NY46 1/20 0.37
▸ MAPT P10636 3/20 0.36
▸ KDM4E B2RXH2 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20122516 0.95 ADRB2 (0.41) ADRB2ADRB1ADRB3KMT2AALDH1A1
SCHEMBL20122555 0.92 ADRB2 (0.40) ADRB2ADRB1ADRB3MEN1KMT2A
SCHEMBL20122445 0.91 ADRB2 (0.41) ADRB2ADRB1ADRB3ALDH1A1HTR1A
SCHEMBL20122394 0.90 KMT2A (0.42) ADRB2ADRB1ADRB3KMT2ASMN1; SMN2
SCHEMBL20122388 0.90 ADRB2 (0.39) ADRB2ADRB1ADRB3ALDH1A1HTR1A
SCHEMBL20122558 0.89 ADRB2 (0.38) ADRB2ADRB1ADRB3NPC1SMN1; SMN2
SCHEMBL20122393 0.89 ADRB2 (0.38) ADRB2ADRB1ADRB3MEN1KMT2A
SCHEMBL20122369 0.89 ACE (0.41) ADRB2ADRB1ADRB3NPC1MEN1
SCHEMBL18650323 0.85 SMN1; SMN2 (0.41) NPC1MEN1KMT2ASMN1; SMN2GAA
SCHEMBL18650347 0.85 SMN1; SMN2 (0.41) NPC1MEN1KMT2ASMN1; SMN2GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9963428-B1 Bucillamine prodrugs, pharmaceutical compositions thereof, and methods of use Nguyen, Mark Quang (US) 2018-05-08 — — US disclosed
Send feedback